News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,454 Results
Type
Article (55119)
Company Profile (183)
Press Release (428152)
Section
Business (134894)
Career Advice (1333)
Deals (20172)
Drug Delivery (61)
Drug Development (65566)
Employer Resources (97)
FDA (10011)
Job Trends (10545)
News (230826)
Policy (18989)
Tag
Academia (2682)
Alliances (38421)
Alzheimer's disease (1087)
Antibody-drug conjugate (ADC) (81)
Approvals (9990)
Artificial intelligence (109)
Bankruptcy (135)
Best Places to Work (8449)
Biotechnology (132)
Breast cancer (144)
Cancer (1211)
Career advice (1112)
CAR-T (73)
Cell therapy (211)
Clinical research (51032)
Collaboration (364)
Compensation (77)
COVID-19 (2009)
C-suite (83)
Cystic fibrosis (71)
Data (965)
Diabetes (100)
Diagnostics (4953)
Earnings (48213)
Employer resources (86)
Events (66504)
Executive appointments (250)
FDA (10406)
Funding (299)
Gene therapy (120)
GLP-1 (410)
Government (2739)
Healthcare (13492)
Infectious disease (2066)
Inflammatory bowel disease (84)
Interviews (262)
IPO (9775)
Job creations (2425)
Job search strategy (970)
Layoffs (290)
Legal (3429)
Lung cancer (192)
Manufacturing (134)
Medical device (6884)
Medtech (6886)
Mergers & acquisitions (10512)
Metabolic disorders (267)
Neuroscience (1292)
NextGen Class of 2024 (4176)
Non-profit (4317)
Northern California (1134)
Obesity (133)
Opinion (154)
Patents (71)
People (39308)
Phase I (16782)
Phase II (22105)
Phase III (16457)
Pipeline (424)
Postmarket research (2265)
Preclinical (7927)
Radiopharmaceuticals (243)
Rare diseases (166)
Real estate (4130)
Regulatory (13800)
Research institute (2532)
Resumes & cover letters (191)
Southern California (955)
Startups (2614)
United States (9862)
Vaccines (438)
Weight loss (83)
Date
Today (21)
Last 7 days (336)
Last 30 days (2722)
Last 365 days (26512)
2024 (24632)
2023 (30055)
2022 (40288)
2021 (42614)
2020 (39084)
2019 (32467)
2018 (24545)
2017 (23606)
2016 (23319)
2015 (27395)
2014 (21138)
2013 (18354)
2012 (18387)
2011 (19056)
2010 (18010)
Location
Africa (610)
Arizona (90)
Asia (30232)
Australia (5735)
California (2438)
Canada (962)
China (217)
Colorado (96)
Connecticut (121)
Europe (70074)
Florida (342)
Georgia (85)
Illinois (235)
Indiana (137)
Maryland (423)
Massachusetts (1879)
Michigan (106)
Minnesota (153)
New Jersey (784)
New York (799)
North Carolina (522)
Northern California (1134)
Ohio (98)
Pennsylvania (535)
South America (714)
Southern California (955)
Texas (397)
Washington State (314)
483,454 Results for "breast cancer research foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifene’s Preclinical Effects on Aromatase Inhibitor Resistant Non-ESR1 Mutated Breast Cancer
Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC), today announced the publication of its scholarly article, “Lasofoxifene as a Potential Treatment for Aromatase Inhibitor-Resistant ER-Positive Breast Cancer,” in the peer-reviewed journal Breast Cancer Research.
June 10, 2024
·
5 min read
Press Releases
Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024
November 25, 2024
·
7 min read
Biotech Bay
Exai Bio to Present New Breast Cancer Data at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Exai Bio today announced new breast cancer data at the American Association for Cancer Research (AACR) 2024 annual meeting.
April 8, 2024
·
4 min read
Antibody-drug conjugate (ADC)
AstraZeneca, Daiichi Sankyo’s ADC Flops in Phase III Breast Cancer on Heels of Lung Cancer Stumble
Monday’s failure to improve overall survival in breast cancer “further dents belief” in the companies’ Dato-DXd and “likely complicates regulatory discussions for approval of this indication,” Jefferies analyst Peter Welford wrote in a note to investors.
September 23, 2024
·
3 min read
·
Tristan Manalac
Approvals
Novartis Pushes Kisqali Into Earlier Stages of Breast Cancer, Nearly Doubles Eligible Patient Population
The FDA’s approval of Kisqali in combination with an aromatase inhibitor allows Novartis to target patients with earlier breast cancer who are at risk of recurrence.
September 18, 2024
·
2 min read
·
Tristan Manalac
Approvals
Roche Wins First-Line Breast Cancer Nod for Oral PI3K Blocker, Projects $2.3B in Peak Sales
With the regulatory approval for advanced breast cancer, Roche’s inavolisib is a potential challenger to Novartis’ PI3K inhibitor Piqray, which last year generated $505 million in revenue.
October 11, 2024
·
2 min read
·
Tristan Manalac
Drug Development
Prostate Cancer Foundation-Funded Research Shows Promising Results Against Lethal Form of Prostate Cancer
A team of investigators at City of Hope funded by the Prostate Cancer Foundation reports that patients with advanced prostate cancer can be safely treated with chimeric antigen receptor T cell therapy.
June 12, 2024
·
4 min read
News
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
October 8, 2024
·
4 min read
Breast cancer
Relay Scores Early Breast Cancer Win, Plans Pivotal Trial Against AstraZeneca’s Truqap
Set to start in 2025, Relay Therapeutics is moving toward a pivotal study of experimental treatment RLY-2608 in heavily pretreated locally advanced or metastatic breast cancer.
September 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Investing in Future Discovery: Breast Cancer Canada Awards Research Fellows
September 16, 2024
·
3 min read
1 of 48,346
Next